<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Guide to tramadol for pain - uses, dosing, and considerations for this atypical opioid pain medication.">
    <meta name="keywords" content="tramadol, Ultram, pain medication, opioid, chronic pain medication">
    <title>Tramadol | ChronicSoreness</title>
    <link rel="stylesheet" href="../css/styles.css">
</head>
<body>
    <header class="header"><nav class="nav-container"><div class="logo"><a href="../index.html"><span class="logo-icon">ðŸ’œ</span><span class="logo-text"><strong>Chronic</strong>Soreness</span></a></div><button class="mobile-menu-toggle" aria-label="Toggle menu"><span class="hamburger"></span></button><ul class="nav-menu"><li><a href="../conditions.html">Conditions</a></li><li><a href="../treatments.html">Treatments</a></li><li><a href="../medications.html">Medications</a></li><li><a href="../exercise.html">Exercise</a></li><li><a href="../nutrition.html">Nutrition</a></li><li><a href="../mental-health.html">Mental Health</a></li></ul></nav></header>
    <main id="main-content">
        <article class="page-header"><h1>Tramadol</h1><p>An atypical opioid pain reliever</p></article>
        <section class="content-section">
            <div class="container">
                <h2>What Is Tramadol?</h2>
                <p>Tramadol is a centrally acting pain reliever with a dual mechanism: weak opioid activity plus effects on serotonin and norepinephrine. It's considered a weaker opioid but still carries risks of dependence and other concerns.<sup>1</sup></p>

                <h2>Brand Names</h2>
                <ul>
                    <li>Ultram (immediate-release)</li>
                    <li>Ultram ER (extended-release)</li>
                    <li>ConZip</li>
                    <li>Also in combination products</li>
                </ul>

                <h2>Uses</h2>
                <ul>
                    <li>Moderate to moderately severe pain</li>
                    <li>Chronic pain (with caution)</li>
                    <li>Sometimes for neuropathic pain</li>
                </ul>

                <h2>Dosing<sup>2</sup></h2>
                <ul>
                    <li><strong>Immediate-release</strong>: 50-100 mg every 4-6 hours</li>
                    <li><strong>Maximum</strong>: 400 mg/day</li>
                    <li><strong>Extended-release</strong>: 100-300 mg once daily</li>
                    <li>Start low, especially in elderly</li>
                </ul>

                <h2>Side Effects<sup>3</sup></h2>
                <ul>
                    <li>Nausea, dizziness</li>
                    <li>Constipation</li>
                    <li>Headache</li>
                    <li>Drowsiness</li>
                    <li>Seizures (especially at high doses)</li>
                    <li>Serotonin syndrome (with certain medications)</li>
                </ul>

                <h2>Important Warnings</h2>
                <ul>
                    <li>Schedule IV controlled substance</li>
                    <li>Can cause physical dependence</li>
                    <li>Seizure risk (especially with SSRIs)</li>
                    <li>Avoid with MAOIs</li>
                    <li>Lower dose in elderly, kidney/liver disease</li>
                    <li>Some people are ultra-rapid metabolizers (risk)</li>
                </ul>

                <h2>Drug Interactions</h2>
                <ul>
                    <li>SSRIs, SNRIs (serotonin syndrome risk)</li>
                    <li>MAOIs (contraindicated)</li>
                    <li>Other CNS depressants</li>
                    <li>CYP2D6 inhibitors/inducers</li>
                </ul>

                <h2>References</h2>
                <ol>
                    <li>Grond S, Sablotzki A. Clinical pharmacology of tramadol. <em>Clin Pharmacokinet</em>. 2004;43(13):879-923.</li>
                    <li>Beakley BD, Kaye AM, Kaye AD. Tramadol, pharmacology, side effects, and serotonin syndrome: a review. <em>Pain Physician</em>. 2015;18(4):395-400.</li>
                    <li>Miotto K, Cho AK, Khalil MA, et al. Trends in tramadol: pharmacology, metabolism, and misuse. <em>Anesth Analg</em>. 2017;124(1):44-51.</li>
                </ol>
            </div>
        </section>
    </main>
    <footer class="footer"><div class="container"><p class="disclaimer">The information provided is for educational purposes only and is not medical advice.</p><p class="copyright">Â© 2024 ChronicSoreness. All rights reserved.</p></div></footer>
    <script src="../js/main.js"></script>
</body>
</html>
